Experts Discuss Policy On Patent Landscapes For Life Sciences – By Kaitlin Mara of IP Watch
India Cancer Patients Seek To Use Courts For Access To Patented Drugs – By Tatum Anderson of IP Watch
Tussle Over Participation In India Compulsory Licence Hearing – IP Watch By Tatum Anderson
Patent Granted for Raltegravir in India
USPTO finds Gilead’s Tenofovir patents invalid following re-examination request by PUBPAT
Unravelling the Valganciclovir patent question in India
Unravelling the Valganciclovir patent question in India
I-MAK Joins Groups in Filing a Public Interest Amici Brief Supporting New U.S Patent Rules
Raltegravir application still pending in India
How do we increase transparency on granted drug patents?